T-wave Alternans and Intrathoracic Impedance Measurements
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
New York |
| State: |
|
New York |
| Zip Code: |
|
10032 |
| Conditions: |
|
Congestive Heart Failure - Arrhythmias |
| Purpose: |
|
T-wave alternans is a test that is currently being used to risk stratify patients with
structural heart disease for sudden cardiac death. The mechanism of T-wave alternans is
unclear, but may share a common abnormality with conditions of cardiac fluid overload such
as heart failure, which is altered intracellular calcium handling. Current Medtronic
implantable defibrillators have the capability of monitoring cardiac fluid status via
transthoracic impedance measurements.
The purpose of this study is to determine if a correlation exists between T-wave alternans
status and cardiac volume status, as determined by transthoracic impedance measurements.
Secondarily, the study seeks to examine the relationship between arrhythmia frequency and
T-wave alternans or cardiac volume status.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Class III or IV heart failure patients with a chronically implanted Medtronic
biventricular defibrillator system capable of monitoring intrathoracic fluid volume.
Exclusion Criteria:
- no active ischemia or pulmonary edema, atrial fibrillation, complete heart block
|
| NCT ID: |
|
NCT00669682 |
| Primary Contact: |
|
Principal Investigator
Jose M Dizon, MD
Columbia University
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
New York, New York 10032
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|